| 2018 | Multiple systemic extraneural metastasis of glioblastoma | 김세훈, 서창옥, 윤진숙, 장종희, 최혜진 |
| 2018 | Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer | 최혜진 |
| 2018 | TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
| 송재진, 최혜진 |
| 2017 | Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
| 송재진, 최혜진 |
| 2017 | Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
| 송재진, 최혜진 |
| 2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| 강석구, 김동석, 김선호, 김세훈, 김의현, 문주형, 박현호, 서창옥, 안성수, 이규성, 이승구, 장종희, 조재호, 최혜진, 홍창기 |
| 2016 | Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study
| 이수현, 최혜진 |
| 2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | 강석구, 김선호, 김세훈, 김의현, 노태훈, 박현호, 서창옥, 안성수, 이규성, 이승구, 장종희, 조재호, 최혜진, 홍창기 |
| 2016 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells | 김주항, 송재진, 최혜진 |
| 2015 | Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib | 김건민, 최혜진, 한광협, 한정우 |
| 2015 | Prediction of short- and long-term survival for advanced cancer patients after ICU admission | 김규리, 손주혁, 이수현, 이충근, 정경수, 최혜진, 허수진 |
| 2015 | Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report.
| 라선영, 박미숙, 서진석, 이영한, 임승택, 최혜진 |
| 2015 | Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma | 강창무, 유영훈, 이우정, 이재훈, 이종두, 최혜진 |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| 김혜련, 김효송, 노미령, 라선영, 신상준, 안중배, 이충근, 정민규, 정현철, 최혜진, 허수진 |
| 2015 | ¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis | 강원준, 김건민, 김주훈, 최혜진 |
| 2015 | Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells | 김주항, 송재진, 최혜진 |
| 2015 | Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer | 최혜진 |
| 2014 | A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma. | 최혜진 |
| 2014 | Prognostic Significance of Volume-Based FDG PET/CT Parameters in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation Therapy
| 강버들, 송시영, 이재훈, 이정원, 이종두, 최혜진 |
| 2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | 성진실, 이수현, 임승택, 임재윤, 장원석, 최혜진, 한광협 |
| 2014 | Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer | 강창무, 송시영, 이우정, 이재훈, 이정원, 이종두, 최혜진 |
| 2013 | Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer
| 강창무, 김주항, 송시영, 윤미진, 이우정, 이재훈, 이종두, 조응혁, 최혜진 |
| 2013 | Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
| 김영재, 이용강, 임승택, 정원재, 최아라, 최혜진, 한정우 |
| 2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| 김주항, 김한상, 김현기, 신상준, 최혜진 |
| 2013 | Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer | 김승일, 김주항, 박병우, 박세호, 손주혁, 이수현, 임승택, 최혜진, 한정우 |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진 |
| 2012 | Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study. | 김도영, 안상훈, 윤상현, 이수현, 최혜진, 한광협 |
| 2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | 강창무, 김현기, 박정엽, 성진실, 송시영, 이우정, 정용은, 최혜진, 황호경 |
| 2012 | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. | 정희철, 최혜진 |
| 2012 | In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas | 강창무, 김유선, 김현기, 이우정, 조유리, 최혜진, 황호경 |
| 2012 | 동영상 운동프로그램이 항암 화학요법을 받는 암환자의 피로와 신체기능 및 정서상태에 미치는 효과
| 이향규, 최혜진 |
| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | 권지은, 김세규, 김주항, 박무석, 손주혁, 심효섭, 양우익, 이익재, 이주희, 이창걸, 최혜진 |
| 2011 | 항암화학요법을 받는 환자의 구강관리 프로토콜개발 및 적용효과
| 김수, 최혜진 |
| 2011 | Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib | 김도영, 박준용, 안상훈, 이재훈, 이종두, 최혜진, 한광협 |
| 2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | 김도영, 김범경, 김자경, 박준용, 안상훈, 이광훈, 이도연, 최혜진, 한광협 |
| 2011 | 전이성 간암의 치료
| 최혜진 |
| 2011 | 진행성 간암에서 전신 요법 | 최혜진 |
| 2011 | Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble?.
| 강창무, 김현기, 박정엽, 이우정, 정용은, 최혜진, 황호경 |
| 2011 | Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using 18F-FDG PET/CTand 99mTc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.
| 강원준, 윤미진, 이재훈, 이종두, 정용휴, 조응혁, 최혜진 |
| 2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| 김소영, 김주항, 선보경, 송재진, 오세은, 응구엔응옥호안, 최혜진 |
| 2010 | Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.
| 김세규, 김주항, 문진욱, 박인규, 이영주, 장준, 조병철, 최혜진 |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | 구자승, 김승일, 김주항, 노재경, 문용화, 박병우, 박세호, 손주혁, 장현, 정현철, 최혜진 |
| 2010 | Outcome of adjuvant therapy for gallbladder cancer | 박준성, 송시영, 윤동섭, 이동기, 이세준, 이우정, 임재윤, 조재용, 최혜진 |
| 2010 | Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients | 김세규, 김주항, 박경수, 이수현, 정민규, 조병철, 최혜진, 홍수정 |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | 금기창, 김남규, 김호근, 노재경, 라선영, 백승혁, 신상준, 안중배, 임준석, 정현철, 정희철, 천재희, 최혜진 |
| 2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | 김귀언, 김주항, 손주혁, 이영주, 이창걸, 조병철, 최은창, 최혜진 |
| 2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정민규, 정재헌, 조병철, 최혜진 |
| 2009 | High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
| 김세규, 김주항, 문진욱, 박인규, 윤미진, 장준, 조병철, 조응혁, 최혜진 |
| 2009 | Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC | 김세현, 김주항, 손주혁, 신상준, 유내춘, 조병철, 최혜진 |
| 2009 | Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma | 김주항, 박경수, 손주혁, 유내춘, 이종두, 이종태, 최혜진 |
(Yonsei Health Research Network)
